Hamid Farhangi

Hamid Farhangi

Auto-generated profile, based on publicly available information

Hamid Farhangi

Department of Pediatrics Hematology and Oncology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
ZBZahra Badiei
Zahra Badiei
MKMaryam Khalesi
Maryam Khalesi
MAMohammad Hasan Alami
Mohammad Hasan Alami
HKHamid Reza Kianifar
Hamid Reza Kianifar
ABAbdollah Banihashem
Abdollah Banihashem
ARAmir Reza Razavi
Amir Reza Razavi
To determine risk factors (RFs) and their relationship with life-threatening infection (LTI) in children with febrile neutropenia (FN). In this cross-sectional study, from December 2008 to November 2009, all children with FN admitted to Dr Sheikh Pediatric Hospital were enrolled. For each patient, demographic, clinical, and laboratory data were recorded and they were followed up for occurrence of LTI. One hundred and twenty episodes of FN in 68 patients were analyzed. The most common underlying disease was acute lymphoblastic leukemia (53.3%), 9 (7.5%) died from an infection and 35 patients (29.1%) had a LTI. Five variables were identified as RFs for LTI, that is, body temperature ≥39°C (P=0.000), presence of mucositis (P=0.000), abnormal chest x-ray (P=0.001), platelet count <20,000/mm3 (P=0.000), and absolute neutrophil count <100/mm3 (P=0.001). Risk of LTI was increasing according to number of RFs presented at the beginning of admission (from 2.8% in patients without RF to 100% in patients with 5 RF). Data mining analysis showed relationship between RFs with platelet count as the most important variable in the high-risk group for LTI. Evaluation of important RFs and judging the severity of patients' condition by studying the importance and relationship between RF at the time of admission can be a useful method for screening LTI in children with FN.

15 June 2016 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Closed access
PDF file
HFHamid Farhangi
Hamid Farhangi
ZBZahra Badiei
Zahra Badiei
HSHassan Mottaghi Moghaddam Shahri
Hassan Mottaghi Moghaddam Shahri
MKMohammad Reza Keramati
Mohammad Reza Keramati

27 December 2017 in Mediterranean Journal of Hematology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
MJMohammad Ehsan Jaripour
Mohammad Ehsan Jaripour
KHKourosh Hayatigolkhatmi
Kourosh Hayatigolkhatmi
VIVahid Iranmanesh
Vahid Iranmanesh
FZFarhad Khadivi Zand
Farhad Khadivi Zand
ZBZahra Badiei
Zahra Badiei
ASAriane Sadr-Nabavi
Ariane Sadr-Nabavi
Background and objective: ß-thalassemia results from a diverse range of mutations inside the hemoglobin subunit β (HBB) gene. In a study of β-thalassemia carriers and some of their at-risk fetuses in the Khorasan province of Iran we aimed to recognize the most common mutations in the region and to find a possible link between these mutations and some of the relevant hematological indices.Methods: Amplification-refractory mutation system-PCR (ARMS-PCR) was used to detect the typical HBB mutations among 1593 individuals, suspected of having a mutated HBB allele from March/2011 to January/2018. Sanger sequencing of HBB had been performed, where ARMS-PCR was uninformative. In some cases, reverse dot blot was utilized. Analysis of variance was used to compare parametric variables.Results: Among 1273 ß-thalassemia carriers, the prevalence of the mutations were reported as follows: IVS-I-5 (42.03%), IVS-II-1 (11.23%), Codons 8/9 (4.79%), Codon 44 (4.56%), codon 15 (3.53%), Los Angeles (2.91%), Codon 5 (2.75%), IVS-I-110 (2.51%), -88 (2.20%) and other mutations were less than 2% of all of the reported mutations. 644 conceptions were subjected to prenatal diagnosis, using chorionic villus sampling. 118 cases were reported as normal. 352 cases were detected as carriers. 174 cases were diagnosed as affected. There was a significant difference in mean corpuscular volume and hemoglobin A2 levels between the 9 most commonly reported mutation types (p<0.001).Conclusion: This study makes a reliable guide for ß-thalassemia diagnosis in the region. The possibility of a correlation between HBB mutations and hematological indices opens a gate of future investigations.

22 August 2012 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
MHMehran Hiradfar
Mehran Hiradfar
NZNona Zabolinejad
Nona Zabolinejad
RSReza Shojaeian
Reza Shojaeian
PSParisa Saeedi
Parisa Saeedi
MJMarjan Joodi
Marjan Joodi
AAAli Alamdaran
Ali Alamdaran

14 June 2021 in International Journal of Cancer Management
Verified
Journal Article
Open access
PDF file
FHFatemeh Sadat Hosseini-Baharanchi
Fatemeh Sadat Hosseini-Baharanchi
ABAhmad Reza Baghestani
Ahmad Reza Baghestani
DBDavood Bashash
Davood Bashash
HBHossein Bonakchi
Hossein Bonakchi
HFHamid Farhangi
Hamid Farhangi
Background: Acute lymphoblastic leukemia (ALL) is the most frequent form of malignant neoplasia diagnosed in ages 0 to 14 years old. Efforts have not yet converted into a better prospect. Bone marrow relapse is still the leading cause of person-year of life lost in this malignancy. Objectives: This study aimed at identifying the associated risk factors for relapse and mortality for pediatric patients with ALL in standard and high-risk groups. Methods: This study included a cohort of pediatric (0 - 16 years old) patients with ALL referred to Sheikh Hospital, Mashhad, Iran from 2007 to 2016. The demographic, clinical, and laboratory information were considered. Hazard ration (HR) with 95% highest posterior density region was obtained, using a Bayesian competing risks model. Results: Of 424 patients with a mean age of 5.56 ± 3.75 years, 172 (40%) were female. Median follow-up time was 43.29 months, 10.6% had a relapse, and 17.2% had mortality related to ALL. Relapse-free survival rates at 1, 3, and 5 years were 97, 91, and 88%, respectively. Overall survival rates were 86, 83, and 82%, respectively. In the standard-risk group, tumor lysis syndrome (TLS) significantly increased either the relapse risk [HR: 13.47 (2.05 - 67.54)] or mortality risk [HR: 19.57 (2.24 - 32.18)]. In the high-risk group, the higher level of hemoglobin, platelet, and lactic acid dehydrogenase was significantly associated with higher relapse risk. TLS was associated with a higher risk of mortality in high-risk groups. Conclusions: It was suggested that TLS was a predictor for the disease relapse as well as mortality in pediatric patients with ALL. However, further evaluation on the larger population of patients is demanded to ascertain the precision of such parameters in leukemic management strategies.

15 March 2016
Verified
Journal Article
Open access
HFH Farhangi
H Farhangi
AGA Ghasemi
A Ghasemi
ABA Banihashem
A Banihashem
ZBZ Badiei
Z Badiei
LJL Jarahi
L Jarahi
TLT Langaee
T Langaee
Immune thrombocytopenic purpura (ITP) is the most prevalent cause of thrombocytopenia in children. Despite the importance of ITP in children under 2-years old, only a few publications are available in the literature.ITP usually presents itself as isolated thrombocytopenia and mucocutaneous bleeding. This study was conducted on 187 under 2-year-old children diagnosed with ITP and treated at Dr. Sheikh Hospital from 2004 to 2011.In this retrospective study, clinical symptoms, laboratory findings, history of viral infections, vaccination history, and treatment efficacy in children under 2-years old with ITP were investigated.Patients were followed for one year after being discharged from the hospital. The risk of the disease developing into chronic form was higher in older children (0.001). ITP in children under 3-months old was significantly associated with vaccination (p=0.007). There was no significant differences between male and female patients in regards to newly diagnosed ITP, persistent, and chronic disease status (p = 0.21). No significant difference in bleeding symptoms was observed between patients under 3-months old and 3 to 24-months old (p=0.18). Infantile ITP respond favorably to treatment. The risk of the disease developing into chronic form is higher in 3-to-24-month-old children compared to under-three-month olds.